The Weekly Litigation News Digest is now live. Subscribe now

Methods Of Treating Fabry Disease In Patients Having A Mutation In The Gla Gene - EP4114390

The patent EP4114390 was granted to Amicus Therapeutics on Dec 4, 2024. The application was originally filed on Mar 5, 2021 under application number EP21715035A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4114390

AMICUS THERAPEUTICS
Application Number
EP21715035A
Filing Date
Mar 5, 2021
Status
Granted And Under Opposition
Nov 1, 2024
Publication Date
Dec 4, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

TEVA PHARMACEUTICALSSep 4, 2025D YOUNGADMISSIBLE
BRAND MURRAY FULLERSep 3, 2025BRAND MURRAY FULLERADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2010113517
DESCRIPTIONUS6274597
DESCRIPTIONUS6583158
DESCRIPTIONUS6589964
DESCRIPTIONUS6599919
DESCRIPTIONUS6916829
DESCRIPTIONUS7141582
DESCRIPTIONUS8592362
INTERNATIONAL-SEARCH-REPORTWO2009102895

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents